Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease.
about
Genotyping Parkinson disease-associated mitochondrial polymorphismMitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model.Mitochondrial biology and Parkinson's diseaseCytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathiesDynamics of Human Mitochondrial Complex I Assembly: Implications for Neurodegenerative DiseasesParkinson's disease as a result of agingMitochondrial DNA sequence variation and neurodegenerationThe cybrid model of sporadic Parkinson's disease.Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson DiseaseMitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy.Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma.Relationships among molecular genetic and respiratory properties of Parkinson's disease cybrid cells show similarities to Parkinson's brain tissuesComplex I deficiency in Parkinson's disease frontal cortex.Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease.Maternal inheritance and mitochondrial DNA variants in familial Parkinson's diseaseRole of mitochondria in Parkinson disease.New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.Neuroproteomics as a promising tool in Parkinson's disease research.Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease.Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise.The neurodegenerative mitochondriopathies.Environment, mitochondria, and Parkinson's disease.Mitochondrial abnormality associates with type-specific neuronal loss and cell morphology changes in the pedunculopontine nucleus in Parkinson diseaseMitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians.Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotection.Cell and animal models of mtDNA biology: progress and prospects.Mitochondrial abnormalities in muscle and other aging cells: classification, causes, and effects.Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease.Mitochondrial respiratory complex I: structure, function and implication in human diseases.Somatic mtDNA variation is an important component of Parkinson's disease.Mitochondria in neurodegeneration.Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence.Genetics of Parkinson disease.The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis?Unregulated mitochondrial GSK3beta activity results in NADH: ubiquinone oxidoreductase deficiency.Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis.Mitochondrial approaches for neuroprotectionThe failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start?
P2860
Q23924039-76BDB2C9-9E65-45BB-B211-A9B540B6C60DQ24634806-73529CC3-ECDF-40C7-93F0-3B5277DC9665Q26824090-B71CED94-7591-4B21-835F-4944B6015C56Q26859496-0BDF168B-D294-4B3E-A4A3-590587A780ACQ28069775-10BB0F33-8F74-475C-B708-5F39BA652D0EQ28084395-5FC752A5-6EEE-4668-BBDA-25FF1D578A1EQ28710285-DEE39CBB-D340-43C5-BF85-41B5B1BE53BFQ28751790-7D668B40-473A-46A6-8D1B-07B0E6E6FDD3Q29398392-12ED080B-B2F0-45E2-A3CF-C85B6B454999Q30306088-1ED0A5BE-D923-4611-881A-905A5E82FC89Q30308666-16879FF3-2D78-420D-BC87-CF75BBF14A4DQ30437451-A849B2C6-4104-46FF-9464-03DF0AAA28FBQ30440448-F79F476E-D842-4E6E-944C-21227EC0054BQ33364885-A9703AAD-1AC2-4C8C-96E5-F083B7406D2AQ33548162-02DA1EDD-1F22-4C75-A225-375970924E5CQ33737269-FB2D08B0-BB37-46F2-AF5F-BED0952FA38EQ33783000-0A10AE0B-2C06-4358-BB60-E0E156227F7DQ33821316-AFC4AB79-E054-4B5D-A1E1-2FE9907518F9Q33836235-8FDBF822-33A2-4CFC-871A-65773D7D3177Q33840243-A9AF6A68-069A-4CF9-BCD5-A4AC30BEC2ABQ33922712-998522FB-F97F-4D7B-BC47-AED81F259D41Q33957065-31850ADF-7E3E-4A35-A8E9-3BD74DD00FE9Q34133031-8D9A525F-3FB4-4F57-B604-A9D8DC5D0EFBQ34299923-0337B676-A2D2-4590-9D81-C90F7BFAE502Q34411109-378BD118-B012-458E-BF21-C1DBEFB5BA60Q34460675-7F1FCA28-036F-429B-8244-CB354A632D1BQ34569830-E8F35760-820A-4F59-A2D3-C0B18A8434AAQ34981294-C70ED0F5-D5A4-4104-BF80-AFFD6597EB66Q35958359-ABDD79B5-4A42-4A9D-B259-39765B9A6F3EQ36372732-9FD0D2F2-76B2-4B7D-8164-D9D5507BB155Q36444688-5BC51A9E-0D84-4FC0-8601-3DF37BE82627Q36595656-632E3832-32DF-46A6-A548-5800D3C825FEQ36745271-23862062-9483-4B52-94B6-661090987BB2Q36813613-A79482C3-48DF-4205-A560-9BCD88BA4255Q37037053-5F6F7F42-C7A7-496F-A3DB-E305D2FDFE31Q37134820-F279D19E-6252-4C09-9CA7-2C9A852F7A71Q37181858-36B12F27-6B5E-4216-A4AA-D3347CBED51DQ37315448-C4175654-3576-43FF-9ABC-9A7C02DF9635Q37348590-17D76B23-77CA-4C4B-8301-C21F3B56DB38Q37441183-33DE86F6-685D-4813-BABD-C597FFA25C63
P2860
Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease.
@en
type
label
Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease.
@en
prefLabel
Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease.
@en
P2093
P356
P1433
P1476
Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease.
@en
P2093
P2860
P304
P356
10.1002/ANA.410440207
P577
1998-08-01T00:00:00Z